Integrated care pathway for rectal cancer treatment

Abstract

Implementation of a rectal cancer ICP reduced all treatment intervals and promoted rational utilization of oncology consultations and imaging, without increment in per-patient costs or detrimental effects in overall survival.

Evaluating Oncology Clinical Pathways: What Bar Are We Aiming for?

“…The large number of patients in the study population and the diversity of cancer types enhance the generalizability of previous research demonstrating cost savings. 7,8 However, questions exist regarding interpretation of the toxicity data and why nondrug costs were greater among patients treated on pathway. The balance between efficacy, toxicity, and ultimately cost are all important factors in selecting regimens for inclusion in a clinical pathway.…”